SCHEMBL25852000

SCHEMBL25852000

c1ccc(-c2cccc(-c3nc(-c4ccc(-c5cccc6c5oc5ccccc56)cc4)nc(-c4ccc5c(c4)oc4ccccc45)n3)c2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.50
PRKDC P78527 2/20 0.45
MMP12 P39900 1/20 0.41
MMP13 P45452 1/20 0.41
GGPS1 O95749 1/20 0.41
MAPT P10636 4/20 0.40
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 2/20 0.40
POLB P06746 1/20 0.40
PLA2G2A P14555 2/20 0.39
PLA2G4A P47712 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
PTGES2 Q9H7Z7 1/20 0.38
HCRTR1 O43613 1/20 0.38
TSHR P16473 2/20 0.37
HPGD P15428 1/20 0.37
PIM1 P11309 1/20 0.37
CSNK2A2 P19784 1/20 0.37
CSNK2B P67870 1/20 0.37
PIM3 Q86V86 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25645723 1.00 ALOX5 (0.50) ALOX5PRKDCMMP12MMP13GGPS1
SCHEMBL26959399 0.99 ALOX5 (0.51) ALOX5PRKDCMMP12MMP13GGPS1
SCHEMBL23913800 0.99 ALOX5 (0.51) ALOX5PRKDCMMP12MMP13GGPS1
SCHEMBL23913846 0.99 ALOX5 (0.51) ALOX5PRKDCMMP12MMP13GGPS1
SCHEMBL24217103 0.98 ALOX5 (0.51) ALOX5PRKDCMMP12MMP13GGPS1
SCHEMBL24097550 0.97 ALOX5 (0.53) ALOX5PRKDCMMP12MMP13GGPS1
SCHEMBL25949967 0.97 ALOX5 (0.47) ALOX5PRKDCMMP12MMP13GGPS1
SCHEMBL25645732 0.97 ALOX5 (0.53) ALOX5PRKDCMMP12MMP13GGPS1
SCHEMBL23228084 0.97 ALOX5 (0.52) ALOX5PRKDCMMP12MMP13GGPS1
SCHEMBL24215962 0.97 ALOX5 (0.52) ALOX5PRKDCMMP12MMP13GGPS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230232717-A1 ORGANIC LIGHT-EMITTING DEVICE, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHTEMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-07-20 US disclosed
US-20230232717-A1 ORGANIC LIGHT-EMITTING DEVICE, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHTEMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230232717-A1 ORGANIC LIGHT-EMITTING DEVICE, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHTEMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE CYBA, AOX1, CYP1A1 ALOX5 369/4885PRKDC 3988/4885MMP12 2917/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.